Profound Medical Corp. (PROF)

Profound Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	210	181	227	233	404	130
Market Cap Growth	-6.02%	-20.21%	-2.53%	-42.20%	210.90%	-
Enterprise Value	185	168	199	182	339	127
PE Ratio	-	-7.23	-18.79	-9.78	-21.06	-8.62
PS Ratio	39.32	33.51	46.62	43.44	70.44	40.73
PB Ratio	6.25	7.74	5.99	3.70	5.29	11.83
P/FCF Ratio	-11.49	-10.82	-12.07	-13.33	-25.01	-11.30
P/OCF Ratio	-11.49	-10.82	-12.07	-13.35	-25.01	-11.30
EV/Sales Ratio	34.67	30.97	40.89	33.87	59.18	39.82
EV/EBITDA Ratio	-7.94	-6.91	-14.82	-8.24	-21.48	-9.29
EV/EBIT Ratio	-7.61	-6.67	-13.63	-7.73	-19.95	-8.57
EV/FCF Ratio	-9.92	-10.00	-10.59	-10.40	-21.01	-11.04
Debt / Equity Ratio	0.16	0.25	0.16	0.02	0.02	0.76
Debt / EBITDA Ratio	-0.27	-0.25	-0.45	-0.05	-0.08	-0.61
Debt / FCF Ratio	-0.34	-0.36	-0.32	-0.06	-0.08	-0.73
Quick Ratio	4.64	5.26	12.63	17.37	18.99	2.18
Current Ratio	5.41	6.58	14.82	18.56	20.33	2.77
Asset Turnover	0.14	0.14	0.09	0.07	0.07	0.11
Interest Coverage	-	-412.62	-	-99.38	-7.98	-113.42
Return on Equity (ROE)	-69.10%	-82.00%	-26.10%	-34.70%	-26.70%	-96.20%
Return on Assets (ROA)	-53.00%	-62.90%	-23.40%	-32.50%	-24.70%	-51.50%
Return on Capital (ROIC)	-55.11%	-73.15%	-53.34%	-36.94%	-19.05%	-58.81%
Earnings Yield	-9.69%	-13.83%	-5.32%	-10.22%	-4.75%	-11.59%
FCF Yield	-7.53%	-9.24%	-8.28%	-7.50%	-4.00%	-8.85%
Buyback Yield / Dilution	-2.35%	-2.35%	-0.51%	-5.83%	-65.58%	-
Total Shareholder Return	-2.35%	-2.35%	-0.51%	-5.83%	-65.58%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).